Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).

CONCLUSION: CRS and HIPEC appear to be safe and effective in patients with peritoneal metastases from unusual cancer sites of origin especially from rare ovarian carcinomas, PM from neuroendocrine tumors. The respective roles of CRS and HIPEC remain unclear and should be evaluated. PMID: 28540827 [PubMed - as supplied by publisher]
Source: International Journal of Hyperthermia - Category: Internal Medicine Tags: Int J Hyperthermia Source Type: research